Delivery Order SPE2DB22D1106-SPE2DB25FFEM3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,223.59 and is scheduled for completion by August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under a larger...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 27, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product with a ceiling value of $1,223.59. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, was competitively awarded with no set-aside designation. The place of performance...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 6, 2025, for pharmaceutical supplies valued at $1,223.59. The contract covers XDEMVY 0.25% DROP 10ML, a specialized pharmaceutical product, with an ultimate completion date of August 27, 2025. The award was made through a competitive process with no set-aside designation and utilizes firm fixed pricing. This delivery order will be fulfilled at AmerisourceBergen's corporate office location...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,223.59 by the Defense Logistics Agency on August 14, 2025, with an ultimate completion date of September 5, 2025. The delivery order is for XDEMVY 0.25% Drop 10ML and utilizes firm fixed price pricing with no set-aside designation. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product, with final completion scheduled for August 18, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product with a ceiling value of $1,223.59. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively...
- This delivery order, valued at $1,223.59, was awarded on July 23, 2025, to AmerisourceBergen Drug Corp for the supply of XDEMVY 0.25% Drop 10ML, a pharmaceutical product. The contract represents a firm fixed price delivery order under a competitive, non-set-aside procurement process. Performance will be completed by August 13, 2025, with fulfillment occurring at AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters. The Defense Logistics Agency, through...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $6,117.95 to AmerisourceBergen Drug Corp on August 18, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is set to be completed by September 9, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML pharmaceutical product with a ceiling value of $1,223.59. This firm fixed-price delivery order, issued on September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is non-competitive with no set-aside designation and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,223.59 by the Defense Logistics Agency (DLA) on July 22, 2025. The award is for XDEMVY 0.25% Drop 10ML, a pharmaceutical product to be delivered to the Conshohocken, PA location with an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order issued under a non-competitive set-aside arrangement and represents a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFEM3Delivery Order
This delivery order, issued by the Defense Logistics Agency (DLA) on August 20, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $2,447.18 for supply of XDEMVY 0.25% Drop 10ML pharmaceutical product. The contract is classified as a child award under a larger vehicle and requires completion by September 11, 2025. No set-aside designation was applied to this competitively awarded contract. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs, holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the underlying vehicle for this delivery order. This prime IDC supports military healthcare programs globally, enabling the company to supply pharmaceutical products, specialty medications, vaccines, and medical devices across multiple therapeutic domains. The current delivery order represents one of numerous fulfillment transactions under this comprehensive pharmaceutical support vehicle that serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/20/25 |